ANNALS OF THE RHEUMATIC DISEASES, cilt.72, sa.8, ss.1308-1314, 2013 (SCI-Expanded)
Background The metabolic syndrome (MetS) may contribute to increased cardiovascular risk in systemic lupus erythematosus (SLE). We aimed to examine the association of demographic factors, lupus phenotype and therapy exposure with the presence of MetS.